Technology

The three major DESTINA technologies are unique and distinguishable from ALL existing enzymatic methods of nucleic acid analysis.

DGL-TechTM

 

A game changing technology for detecting nucleic acids and their mutations.

ChemiRNATM Tech

 

Direct detection and absolute quantification of miRNAs from body fluids.

Spin-Tube Device

 

An easy-to-use and inexpensive device for nucleic acid testing.

Products & Services

Products

DESTINA is developing liquid biopsy assays for an earlier and accurate diagnosis, overcoming many of the limitations of current tests.

Services

Our Staff can upgrade your actual miRNA profiling into reliable, direct and absolute quantification of your target miRNA using ChemiRNA™ Tech.

Custom PNA synthesis

Our team is capable to design, synthesize and supply PNAs following strict quality control protocols to meet customer needs.

DESTINA News

 

 

Investors & Partners

Investment Opportunity

DESTINA has  managed  since  its formation  to  balance its technology  and early stage commercial  developments through careful  management…

Collaborations

DESTINA  has  developed  a  range  of  strong  collaborations  with  Universities  in  the  UK,  Spain,  Italy,  Belgium  and  Greece,  and  in  particular…

Grants

DESTINA is a leading and reliable partner in a number of promising European GRANTS. DESTINA’s focus is on using its innovative technology…